Products
China Factory for Ca199 Tumor Marker - POCT CLIA System lumilite 8 – Illumaxbio
China Factory for Ca199 Tumor Marker - POCT CLIA System lumilite 8 – Illumaxbio Detail:
Description
Lumilite 8 is a 25cm, easy to use, bench-top chemiluminescent immunoassay analyzer providing affordable, core-lab quality results from whole blood/serum/plasma samples in under 15 minutes. A broad menu of tests to support better differentiation from a single sample, on a single run, on a single instrument.
With the flexibility to run up to 8 tests simultaneously, and self-developed bead separation system & intelligent single photon counting module, Lumilite 8 ensures highly accurate and precision results (CV≤5%).
With Only 12kg and 3-step operation, Lumilite 8 provides easy to use point-of-care solutions outside the core lab, providing immediate results and thus allowing treatment decisions to be made more quickly – inside or outside the hospital.
Product Features
1.Sample types: run whole blood/plasma/serum samples, no sample preparation, no manual dilutions.
2.Rapid turnaround time: It can run 8 simultaneous tests in under 15 minutes, and up to 32 tests per hour.
3.Flexibility : perform any of the assays – from 1 to 8 tests per run.
4.Broad menu: over 100 parameters available in single-test ready-to-use format.
5.Light weight: only 12kg.
6.On-demand testing: 1 patient, 1 test, 1 result, ready-to-use reagents.
7.Cost effective: no liquid, no consumable, no carryover, minimum maintenance.
Specifications
| Measuring principle | Chemiluminescence enzyme immunoassay technology (CLIA) |
| Throughput | 32 T/H |
| Sample type | whole blood/ serum/ plasma |
| Reaction temperature | 37℃ |
| Display | 8′ touch screen |
| Electrical requirements | AC100-240V |
| Reagent scanner | Intergrated |
| Sample scanner | Intergrated |
| Thermal printer | Intergrated |
| Interface | USB*2、RJ45 |
| Dimension(W*D*H) | 228*385*256mm |
| Weight | 12kg |
Product Description
The POCT CLIA System lumilite 8 is a quantitative and accurate immunoassay analysis system. It utilizes the ALP enzymatic cheminluminescence system which is easy to operate and fast to measure. It adopts self-developed versatile magnetic bead separation technology and intelligent single photon counting module to minimize interference and greatly improves the precision of detection.
Product Application
Lumilite 8 is only cola height with precision results, so it is widely used in ambulances, cardiology, emergency, CPC, ICU, clinic, , field troops…
Product Details
01
SDI
Software define immunoassay
Handle complicated workflow easily
Better adaptability than tranditional CLIA system
02
VBS
Versatile bead separation
Automatic Pierce
Precise sample adding
Efficient bead separation
Magnetic beads mixing
03
AOI
Automatic optical inspection
Identify anomalies through the AI visual to guarantee the reliability of system
04
OTA
Over the air
Remote maintenance and upgrade
05
ISPCM
Intelligent single photon counting module
06
Technology
Develpoed with newest technology
Wide linear
Low noise
Integrated Shutter
Built-in correction algorithm
Product detail pictures:
Related Product Guide:
We normally follow the basic principle "Quality Initial, Prestige Supreme". We've been fully committed to offering our consumers with competitively priced good quality merchandise, prompt delivery and professional support for China Factory for Ca199 Tumor Marker - POCT CLIA System lumilite 8 – Illumaxbio , The product will supply to all over the world, such as: Buenos Aires, Birmingham, Egypt, Strict quality control is executed in each link of the whole production process.We sincerely hope to establish the friendly and mutual-beneficial cooperation with you. Based on high quality products and perfect pre-sales /after-sales service is our idea, some clients had cooperated with us for more than 5 years.
By John biddlestone from Durban - 2017.10.25 15:53
Adhering to the business principle of mutual benefits, we have a happy and successful transaction, we think we will be the best business partner.
By Victoria from Germany - 2018.11.04 10:32
